annb0t
Top 20
Opthea Limited
MELBOURNE, Australia, March 10, 2022 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced today that Dr Megan Baldwin, the Companyâs Chief Executive Officer, will present at Oppenheimerâs 32nd Annual Healthcare Conference, being held virtually from March 15-17, 2022.
The presentation will be available beginning Tuesday, March 15, at 8:40 ...
>>> Read more: Opthea To Present at Oppenheimerâs 32nd Annual Healthcare Conference
MELBOURNE, Australia, March 10, 2022 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced today that Dr Megan Baldwin, the Companyâs Chief Executive Officer, will present at Oppenheimerâs 32nd Annual Healthcare Conference, being held virtually from March 15-17, 2022.
The presentation will be available beginning Tuesday, March 15, at 8:40 ...
>>> Read more: Opthea To Present at Oppenheimerâs 32nd Annual Healthcare Conference
